Interferon-induced epithelial response to rhinovirus 16 in asthma relates to inflammation and FEV1

Journal of Allergy and Clinical Immunology

Volumn 143, Issue 1, 2019, Pages 442-447.e10

  Ravi, Abilash ^a,b   Koster, Jan ^a   Dijkhuis, Annemiek ^a   Bal, Suzanne M ^a,b   Sabogal Piñeros, Yanaika S ^a,b   Bonta, Peter I ^b   Majoor, Christof J ^b   Sterk, Peter J ^b   Lutter, René ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b University of Amsterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN E; INTERFERON; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 6; INTERLEUKIN 8; MYELOPEROXIDASE;

ALLERGIC ASTHMA; ARTICLE; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; BRONCHOALVEOLAR LAVAGE FLUID; CORRELATIONAL STUDY; EOSINOPHIL COUNT; FORCED EXPIRATORY VOLUME; FRACTIONAL EXHALED NITRIC OXIDE; GENE EXPRESSION; GENE ONTOLOGY; HUMAN; HUMAN RHINOVIRUS A16; IN VITRO STUDY; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM CELL; LUNG FUNCTION; PRICK TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; RHINOVIRUS INFECTION; RNA ISOLATION; TRANSCRIPTOMICS; VIRAL RESPIRATORY TRACT INFECTION; VIRUS LOAD; BRONCHUS; CLINICAL TRIAL; EPITHELIUM CELL; FEMALE; IMMUNOLOGY; MALE; MULTICENTER STUDY; PATHOLOGY; PICORNAVIRUS INFECTION; RHINOVIRUS; TH2 CELL; VIROLOGY;

ASTHMA; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; EPITHELIAL CELLS; FEMALE; HUMANS; INTERFERON TYPE I; MALE; PICORNAVIRIDAE INFECTIONS; RHINOVIRUS; TH2 CELLS;

EID: 85055734817     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2018.09.016     Document Type: Article

References (15)

1. Busse, W.W., Lemanske, R.F. Jr., Gern, J.E., Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 376 (2010), 826–834.
2. Wark, P.A., Johnston, S.L., Bucchieri, F., Powell, R., Puddicombe, S., Laza-Stanca, V., et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 201 (2005), 937–947.
3. Jackson, D.J., Makrinioti, H., Rana, B.M., Shamji, B.W., Trujillo-Torralbo, M.B., Footitt, J., et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med 190 (2014), 1373–1382.
4. Sykes, A., Edwards, M.R., Macintyre, J., del Rosario, A., Bakhsoliani, E., Trujillo-Torralbo, M.B., et al. Rhinovirus 16-induced IFN-alpha and IFN-beta are deficient in bronchoalveolar lavage cells in asthmatic patients. J Allergy Clin Immunol 129 (2012), 1506–1514.e6.
5. Hansel, T.T., Tunstall, T., Trujillo-Torralbo, M.B., Shamji, B., Del-Rosario, A., Dhariwal, J., et al. A comprehensive evaluation of nasal and bronchial cytokines and chemokines following experimental rhinovirus infection in allergic asthma: increased interferons (IFN-gamma and IFN-lambda) and type 2 inflammation (IL-5 and IL-13). EBioMedicine 19 (2017), 128–138.
6. Bochkov, Y.A., Hanson, K.M., Keles, S., Brockman-Schneider, R.A., Jarjour, N.N., Gern, J.E., Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol 3 (2010), 69–80.
7. van der Sluijs, K.F., van de Pol, M.A., Kulik, W., Dijkhuis, A., Smids, B.S., van Eijk, H.W., et al. Systemic tryptophan and kynurenine catabolite levels relate to severity of rhinovirus-induced asthma exacerbation: a prospective study with a parallel-group design. Thorax 68 (2013), 1122–1130.
8. Wark, P.A.B., Bucchieri, F., Johnston, S.L., Gibson, P.G., Hamilton, L., Mimica, J., et al. IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations. J Allergy Clin Immunol 120 (2007), 586–593.
9. Woodruff, P.G., Boushey, H.A., Dolganov, G.M., Barker, C.S., Yang, Y.H., Donnelly, S., et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A 104 (2007), 15858–15863.
10. Miller, M.R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., et al. Standardisation of spirometry. Eur Respir J 26 (2005), 319–338.
11. Sterk, P.J., Fabbri, L.M., Quanjer, P.H., Cockcroft, D.W., O'Byrne, P.M., Anderson, S.D., et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16 (1993), 53–83.
12. Hoogerwerf, J.J., de Vos, A.F., Levi, M., Bresser, P., van der Zee, J.S., Draing, C., et al. Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide. Crit Care Med 37 (2009), 619–625.
13. Rijssenbeek-Nouwens, L.H., Fieten, K.B., Bron, A.O., Hashimoto, S., Bel, E.H., Weersink, E.J., High-altitude treatment in atopic and nonatopic patients with severe asthma. Eur Respir J 40 (2012), 1374–1380.
14. Boorsma, M., Lutter, R., van de Pol, M.A., Out, T.A., Jansen, H.M., Jonkers, R.E., Repeatability of inflammatory parameters in induced sputum of COPD patients. COPD 4 (2007), 321–329.
15. Jansen, R.R., Wieringa, J., Koekkoek, S.M., Visser, C.E., Pajkrt, D., Molenkamp, R., et al. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J Clin Microbiol 49 (2011), 2631–2636.